Page last updated: 2024-08-23

tetradecanoylphorbol acetate and ci 949

tetradecanoylphorbol acetate has been researched along with ci 949 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adolphson, RL; Chestnut, JC; Conroy, MC; Kennedy, JA; Thueson, DO; Wright, CD1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and ci 949

ArticleYear
Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.
    The Journal of allergy and clinical immunology, 1990, Volume: 86, Issue:6 Pt 1

    Topics: Basophils; Calcimycin; Dose-Response Relationship, Drug; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; Indoles; Lung; Mast Cells; SRS-A; Tetradecanoylphorbol Acetate; Tetrazoles; Thromboxane B2

1990